{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:46:30Z","timestamp":1767015990928,"version":"3.41.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","primarycare.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.pop.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T18:30:35Z","timestamp":1507746635000},"page":"631-642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatitis C"],"prefix":"10.1016","volume":"44","author":[{"given":"Dee Ann","family":"Bragg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Crowl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Manlove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pop.2017.07.006_bib1","first-page":"835","article-title":"Diagnosis and management of hepatitis C","volume":"91","author":"Wilkins","year":"2015","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.pop.2017.07.006_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.pop.2017.07.006_bib3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1478-3231.2011.02494.x","article-title":"Hepatitis C virus infection in USA: an estimate of true prevalence","volume":"31","author":"Chak","year":"2011","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.pop.2017.07.006_bib4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/ciw111","article-title":"Rising mortality associated with hepatitis C virus in the United States, 2003-2013","volume":"62","author":"Ly","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.pop.2017.07.006_bib5","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1377\/hlthaff.2014.0096","article-title":"Hospitalizations and costs associated with hepatitis C and advanced liver disease continue to increase","volume":"33","author":"Xu","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"10.1016\/j.pop.2017.07.006_bib6","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1128\/JCM.05292-11","article-title":"Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results","volume":"49","author":"Kesli","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.pop.2017.07.006_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.pop.2017.07.006_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2017.07.006_bib9","series-title":"Pathologic basis of disease","first-page":"821","article-title":"Liver and gallbladder","author":"Theise","year":"2015"},{"issue":"1 Suppl","key":"10.1016\/j.pop.2017.07.006_bib10","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jhep.2016.07.039","article-title":"Reversion of disease manifestations after HCV eradication","volume":"65","author":"van der Meer","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.pop.2017.07.006_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.pop.2017.07.006_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/jamainternmed.2014.6502","article-title":"Liver fibrosis progression in hepatitis C virus infection after seroconversion","volume":"175","author":"Butt","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.pop.2017.07.006_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cgh.2009.11.018","article-title":"A\u00a0sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus","volume":"8","author":"Singal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.pop.2017.07.006_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pop.2017.07.006_bib15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.pop.2017.07.006_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.drugpo.2015.05.001","article-title":"The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: a systematic review of the literature","volume":"26","author":"Coats","year":"2015","journal-title":"Int J Drug Pol"},{"issue":"18","key":"10.1016\/j.pop.2017.07.006_bib17","first-page":"362","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.pop.2017.07.006_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2893.2001.00280.x","article-title":"Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature","volume":"8","author":"Colin","year":"2001","journal-title":"J\u00a0viral Hepat"},{"issue":"5 Suppl 1","key":"10.1016\/j.pop.2017.07.006_bib19","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1002\/hep.1840360709","article-title":"Use and interpretation of virological tests for hepatitis C","volume":"36","author":"Pawlotsky","year":"2002","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.pop.2017.07.006_bib20","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.3748\/wjg.v20.i13.3431","article-title":"Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging","volume":"20","author":"Saludes","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.pop.2017.07.006_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Castera","year":"2005","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pop.2017.07.006_bib22","first-page":"445","article-title":"Evaluation of liver fibrosis: \u201cSomething old, something new\u2026\u201d","volume":"29","author":"Almpanis","year":"2016","journal-title":"Ann Gastroenterol"},{"issue":"5","key":"10.1016\/j.pop.2017.07.006_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-159-5-201309030-00021","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection","volume":"159","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.pop.2017.07.006_bib24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00535-016-1216-y","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2015","volume":"51","author":"Fukui","year":"2016","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pop.2017.07.006_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: a review","volume":"3","author":"Balogh","year":"2016","journal-title":"J\u00a0Hepatocell Carcinoma"},{"issue":"3","key":"10.1016\/j.pop.2017.07.006_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-015-9684-3","article-title":"Hepatitis C virus as a systemic disease: reaching beyond the liver","volume":"10","author":"Gill","year":"2016","journal-title":"Hepatol Int"},{"issue":"7","key":"10.1016\/j.pop.2017.07.006_bib27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pop.2017.07.006_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13027-016-0076-7","article-title":"Systemic manifestations of hepatitis C infection","volume":"11","author":"Tang","year":"2016","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"10.1016\/j.pop.2017.07.006_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis","volume":"62","author":"Simmons","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pop.2017.07.006_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1741-7015-9-70","article-title":"The role of lifestyle changes in the management of chronic liver disease","volume":"9","author":"Nobili","year":"2011","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.pop.2017.07.006_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cgh.2007.10.021","article-title":"Influence of cannabis use on severity of hepatitis C disease","volume":"6","author":"Ishida","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.pop.2017.07.006_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5 Suppl 1","key":"10.1016\/j.pop.2017.07.006_bib33","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1002\/hep.1840360712","article-title":"Prevention of spread of hepatitis C","volume":"36","author":"Alter","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.pop.2017.07.006_bib34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri3463","article-title":"25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end","volume":"13","author":"Heim","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.pop.2017.07.006_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/liv.12409","article-title":"A\u00a0brief history of hepatitis milestones","volume":"34","author":"Trepo","year":"2014","journal-title":"Liver Int"},{"issue":"9916","key":"10.1016\/j.pop.2017.07.006_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(13)62121-2","article-title":"Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial","volume":"383","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2017.07.006_bib37","unstructured":"Epclusa\u00ae [package insert]. Foster City, CA: Gilead Sciences I; 2016."},{"key":"10.1016\/j.pop.2017.07.006_bib38","unstructured":"Zepatier\u2122 [package insert]. Kenilworth, NJ: Merck & Co I; 2016."},{"key":"10.1016\/j.pop.2017.07.006_bib39","unstructured":"Daklinza\u2122 [package insert]. NY: Bristol-Myers Squibb Company NY; 2015."},{"key":"10.1016\/j.pop.2017.07.006_bib40","unstructured":"Technivie\u2122 [package insert]. North Chicago, IL: AbbVie I; 2015."},{"key":"10.1016\/j.pop.2017.07.006_bib41","unstructured":"Viekira Pak\u00ae [package insert]. North Chicago, IL: AbbVie I; 2014."},{"key":"10.1016\/j.pop.2017.07.006_bib42","unstructured":"Harvoni\u00ae [package insert]. Foster City, CA: Gilead Sciences I; 2014."},{"key":"10.1016\/j.pop.2017.07.006_bib43","unstructured":"Sovaldi\u00ae [package insert]. Foster City, CA: Gilead Sciences I; 2013."},{"key":"10.1016\/j.pop.2017.07.006_bib44","unstructured":"Olysio\u00ae [package insert]. Titusville, NJ: Janssen Products L; 2013."},{"issue":"3","key":"10.1016\/j.pop.2017.07.006_bib45","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454317301008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454317301008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T09:13:05Z","timestamp":1750929185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454317301008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0095454317301008"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2017.07.006","relation":{},"ISSN":["0095-4543"],"issn-type":[{"type":"print","value":"0095-4543"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}